Display Settings:

Format

Send to:

Choose Destination

    Diabetes Care. 2004 Sep;27(9):2103-7.

    Haptoglobin phenotype and gestational diabetes.

    Mustafa S, Vukovich T, Prikoszovich T, Winzer C, Schneider B, Esterbauer H, Wagner O, Kautzky-Willer A.

    Institute of Medical and Chemical Laboratory Diagnostics, Wien, Währingergürtel, Austria.

    OBJECTIVE: Haptoglobin (Hp), an Hb-binding plasma protein, exists in two major allelic variants. Hp1 has higher Hb binding and antioxidant capacity compared with Hp2. Individuals with Hp1 exhibit a lower incidence of angiopathies. Gestational diabetes mellitus (GDM) is an early manifestation of type 2 diabetes in pregnant women. It is usually confined to the time of gestation, but carries an increased risk to develop type 2 diabetes later in life. RESEARCH DESIGN AND METHODS: From consecutive Caucasian pregnant women (n = 250) referred for oral glucose tolerance testing, the Hp phenotype was determined. Significance of distribution and odds ratios (ORs) associated with Hp phenotype were calculated for women with GDM (n = 110) and women with normal glucose tolerance (n = 140). RESULTS: -Frequency of GDM in Hp phenotype classes increased with the number of Hp2 alleles (P < 0.001). ORs for GDM in women heterozygous and homozygous for Hp2 were 2.7 (95% CI 1.06-6.84) and 4.2 (1.67-10.55), respectively. CONCLUSIONS: Hp phenotype is an apparent risk factor for the development of GDM in our study population. This might be due to the low antioxidative potential of Hp2 compared with Hp1.

    PMID: 15333469 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read